NantHealth Leans Toward IPO with Allscripts Buy-In
In a move that sets NantHealth up for an IPO by the end of the year, Allscripts (NASDAQ: MDRX) has purchased a 10 percent stake in the Culver City healthcare IT company for $200 million …[READ MORE]